It can directly bind to PI3K to inhibit the PI3K/AKT signaling pathway, further inhibiting the nuclear factor kappa‐B (NF‐kB) pathway and reducing NF‐KB‐mediated angiogenesis and tumor invasion [69]. The gene discussed is NFKB1; the disease is neoplasm.